Connection

Pankaj Bhardwaj to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Pankaj Bhardwaj has written about Antibodies, Monoclonal, Humanized.
Pankaj Bhardwaj
Connection Strength
0.048
Antibodies, Monoclonal, Humanized
  1. Tocilizumab in COVID-19: a study of adverse drug events reported in the WHO database. Expert Opin Drug Saf. 2021 Sep; 20(9):1125-1136.
    View in: PubMed
    Score: 0.048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.